SciSparc Ltd. (SPRC) has released an update.
SciSparc Ltd., a biopharmaceutical firm focusing on central nervous system disorders, has been notified by Nasdaq of non-compliance with the stock exchange’s minimum bid price rule. The company has 180 days, until January 13, 2025, to meet the $1.00 per share minimum bid requirement. If compliance is not demonstrated within the grace period, SciSparc risks delisting from the Nasdaq market.
For further insights into SPRC stock, check out TipRanks’ Stock Analysis page.
